Clopidogrel administration prior to coronary artery bypass grafting surgery: The cardiologist's panacea or the surgeon's headache?

European Heart Journal

Volumn 26, Issue 6, 2005, Pages 576-583

  Kapetanakis, Emmanouil I ^a   Medlam, Diego A ^a   Boyce, Steven W ^a   Haile, Elizabeth ^b   Hill, Peter C ^a   Dullum, Mercedes K C ^a   Bafi, Ammar S ^a   Petro, Kathleen R ^a   Corso, Paul J ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

Author keywords

Clopjdogrel; Coronary artery bypass graft surgery; Haemostasis; Re operation due to bleeding; Transfusion rates

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN;

ADULT; AGED; BLOOD TRANSFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE CONCENTRATE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; REVIEW; RISK ASSESSMENT; SURGICAL MORTALITY; THROMBOSIS;

AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PREMEDICATION; PROSPECTIVE STUDIES; REOPERATION; RISK FACTORS; THROMBOSIS; TICLOPIDINE;

EID: 16244395149     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi074     Document Type: Review

References (36)

1. Kam PCA, Nethery CM. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical development. Anesthesia 2002;58:28-35.
2. Harker LA, Boissel JP, Pilgrim AJ et al. Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel vs. Aspirin in Patients at Risk of Ischaemic Events. Drug Saf 1999;21:325-335.
3. CURE study investigators. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Programme. Eur Heart J 2000;21:2033-2041.
4. Mitka M. Results of CURE trial for acute coronary syndrome. JAMA 2001;285:1828-1829.
5. Hongo R, Ley J, Dick S et al. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting, J Amer Coll Cardiol 2002;40:231-237.
6. Schomig A, Neumann FJ, Kastrati A et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 1996;334:1084-1089.
7. Mishkel GJ, Aguirre FV, Ligon RW et al. Clopidogrel as adjunctive anti-platelet therapy during coronary stenting. J Am Coll Cardiol 1999;34:1884-1890.
8. Moussa I, Oetgen M, Roubin G et al. Effectiveness of clopidogrel and aspirin vs. ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 1999;99:2364-2366.
9. Jauhar R, Bergman G, Savino S et al. Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting. Am J Cardiol 1999;84:726-728.
10. Leon MB, Bairn DS, Popma JJ et al. A clinical trial comparing three anti-thrombotic drug regimens after coronary artery stenting. Stent Anti-coagulation Re-stenosis Study Investigators. N Engl J Med 1998;339:1665-1671.
11. Steinhubl SR, Berger PB, Mann JT III. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-2420.
12. Herbert JM, Tissinier A, Vallee E et al. Clopidogrel, a novel antiplatelet and antithrombotic agent. Cardiovasc Drug Rev 1993;11: 180-198.
13. Savcic M, Hauert J, Bachmann F et al. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Haemost 1999;2:15-19.
14. Taniuchi M, Kurz HI, Lasala JM. Randomized comparison of ticlopidine and clopidogrel after intra-coronary stent implantation in a broad patient population. Circulation 2001;104:539-543.
15. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel vs. aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339.
16. Hankey GJ, Sudlow CL, Dunbabin DW. Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials. Stroke 2000;31:1779-1784.
17. Gansera B, Schmidtler F, Spiliopoulos K et al. Urgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapy. Thorac Cardiovasc Surs 2003;51:185-189.
18. Hongo R, Ley J, Dick S et al. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Amer Coll Cardiol 2002;40:231-237.
19. Yende S, Wunderink R. Effect of clopidogrel after coronary artery bypass surgery. Crit Care Med 2001;29:2271-2275.
20. Bernstein AD, Parsonnet V. Bedside estimation of risk as an aid for decision-making in cardiac surgery. Ann Thorac Surg 2000;69: 823-828.
21. Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989;79(Suppl. 1):3-12.
22. Berkowitz SD, Granger CB, Pieper KS et al. Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The GUSTO I Investigators. Circulation 1997;95: 2508-2516.
23. Parr KG, Patel MA, Dekker R et al. Multivariate predictors of blood product use in cardiac surgery. J Cardiothorac Vasc Anesth 2003;17:176-181.
24. Covin R, O'Brien M, Grunwald G et al. Factors affecting transfusion of fresh frozen plasma, platelets, and red blood cells during elective coronary artery bypass graft surgery. Arch Pathol Lab Med 2003; 127:415-423.
25. Rubin DB, Thomas N. Matching using estimated propensity scores; relating theory to practice. Biometrics 1996;52:249-264.
26. Grunkemeier GL, Payne N, Jin R et al. Propensity score analysis of stroke after off-pump coronary artery bypass grafting. Ann Thorac Surg 2002;74:301-305.
27. Diggle PJ, Liang, KY, Zeger SL. The analysis of longitudinal data. New York: Oxford University Press; 1994.
28. Steinhubl SR, Berger PB, Mann TJ et al. Early and sustained dual oral anti-platelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-2420.
29. Hebert PC, Schweitzer I, Blajchman MA et al. A multi-center, randomized, controlled clinical trial of transfusion requirements in critical care. Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-417.
30. Dacey U, Munoz JJ, Baribeau YR et al. Re-exploration for haemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg 1998;133:442-447.
31. Engoren MC, Habib RH, Zacharias A et al. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thor Surg 2002;74:1180-1186.
32. Weltermann A, Fritsch P, Kyrle PA et al. Effect of pre-treatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting. Thromb Res 2003;112:19-24.
33. Jaremo P, Lindahal TL, Fransson G et al. Individual variations of platelet inhibition after loading doses of clopidogrel. J Inter Med 2002;252:233-238.
34. Gurbel PA, Bilden KP, Hiatt BL et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-2913.
35. Muller I, Besta F, Schulz C et al. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost, 2003; 89:783-787.
36. Jaremo P, Lindahl TL, Fransson SG et al. Individual variations of platelet inhibition after loading doses of clopidogrel. J Intern Med 2002;252:233-238.